TITLE

Handling Uncertainty in Dynamic Models: The Pentose Phosphate Pathway in Trypanosoma brucei

AUTHOR(S)
Kerkhoven, Eduard J.; Achcar, Fiona; Alibu, Vincent P.; Burchmore, Richard J.; Gilbert, Ian H.; Trybiło, Maciej; Driessen, Nicole N.; Gilbert, David; Breitling, Rainer; Bakker, Barbara M.; Barrett, Michael P.
PUB. DATE
December 2013
SOURCE
PLoS Computational Biology;Dec2013, Vol. 9 Issue 12, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Dynamic models of metabolism can be useful in identifying potential drug targets, especially in unicellular organisms. A model of glycolysis in the causative agent of human African trypanosomiasis, Trypanosoma brucei, has already shown the utility of this approach. Here we add the pentose phosphate pathway (PPP) of T. brucei to the glycolytic model. The PPP is localized to both the cytosol and the glycosome and adding it to the glycolytic model without further adjustments leads to a draining of the essential bound-phosphate moiety within the glycosome. This phosphate “leak” must be resolved for the model to be a reasonable representation of parasite physiology. Two main types of theoretical solution to the problem could be identified: (i) including additional enzymatic reactions in the glycosome, or (ii) adding a mechanism to transfer bound phosphates between cytosol and glycosome. One example of the first type of solution would be the presence of a glycosomal ribokinase to regenerate ATP from ribose 5-phosphate and ADP. Experimental characterization of ribokinase in T. brucei showed that very low enzyme levels are sufficient for parasite survival, indicating that other mechanisms are required in controlling the phosphate leak. Examples of the second type would involve the presence of an ATP:ADP exchanger or recently described permeability pores in the glycosomal membrane, although the current absence of identified genes encoding such molecules impedes experimental testing by genetic manipulation. Confronted with this uncertainty, we present a modeling strategy that identifies robust predictions in the context of incomplete system characterization. We illustrate this strategy by exploring the mechanism underlying the essential function of one of the PPP enzymes, and validate it by confirming the model predictions experimentally.
ACCESSION #
93395150

 

Related Articles

  • Inhibitors of Trypanosoma brucei 6-Phosphogluconate Dehydrogenase. Hanau, S.; Montin, K.; Gilbert, I. H.; Barrett, M. P.; Dallocchio, F. // Current Bioactive Compounds;Sep2007, Vol. 3 Issue 3, p161 

    6-Phosphogluconate dehydrogenase (6PGDH) is the third enzyme of the pentose phosphate pathway. It converts 6- phosphogluconate to ribulose 5-phosphate and concomitantly provides NADPH required for many biosynthetic and detoxification reactions. Its presence has been shown to be essential for...

  • Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Schafer, Zachary T.; Grassian, Alexandra R.; Song, Loling; Jiang, Zhenyang; Gerhart-Hines, Zachary; Irie, Hanna Y.; Gao, Sizhen; Puigserver, Pere; Brugge, Joan S. // Nature;9/3/2009, Vol. 461 Issue 7260, p109 

    Normal epithelial cells require matrix attachment for survival, and the ability of tumour cells to survive outside their natural extracellular matrix (ECM) niches is dependent on acquisition of anchorage independence. Although apoptosis is the most rapid mechanism for eliminating cells lacking...

  • Metabolism: Brucei's next top model. Goodman, Catherine // Nature Chemical Biology;Feb2014, Vol. 10 Issue 2, p86 

    The article focuses on a research which was published in the 2013 issue of the periodical "PLOS Computational Biology" related to the finding of new drug targets for cellular metabolism on existing metabolic models of Trypanosoma brucei.

  • Significance of the non-oxidative route of the pentose phosphate pathway for supplying carbon to the purine-nucleotide pathway in Corynebacterium ammoniagenes. Kamada, N.; Yasuhara, A.; Ikeda, M. // Journal of Industrial Microbiology & Biotechnology;Feb2003, Vol. 30 Issue 2, p129 

    To evaluate the strategy of supplying ribose 5-phosphate to the purine-nucleotide pathway exclusively via the nonoxidative route, the glucose 6-phosphate dehydrogenase gene zwf was disrupted in inosine- and 5'-xanthylic acid-producers of Corynebacterium ammoniagenes. In both producers,...

  • Phosphagen Kinases of Parasites: Unexplored Chemotherapeutic Targets. Jarilla, Blanca R.; Agatsuma, Takeshi // Korean Journal of Parasitology;Dec2010, Vol. 48 Issue 4, p281 

    No abstract available.

  • Comparison of Organ Weights of Wild and Laboratory Microtus montanusInfected with Trypanosoma brucei gambiense Pinter, Aelita J.; Ackerman, Steven; King, Lucy; Seed, John R.; Ashman, Portia U. // American Midland Naturalist;Jul1978, Vol. 100 Issue 1, p126 

    No abstract available.

  • Serum-Stable RNA Aptamers to an Invariant Surface Domain of Live African Trypanosomes. Homann, Matthias; Lorger, Mihaela; Engstler, Markus; Zacharias, Martin; G�ringer, H. Ulrich // Combinatorial Chemistry & High Throughput Screening;Aug2006, Vol. 9 Issue 7, p491 

    African trypanosomes are extracellular blood parasites that cause sleeping sickness in humans and Nagana in cattle. The therapeutics used to control and treat these diseases are very ineffective and thus, the development of new drugs is urgently needed. We have previously suggested to use...

  • TrypanoCyc -- a metabolic pathway database for Trypanosoma brucei. Chukualim, Bridget; Peters, Nick; Fowler, Christiane Hertz; Berriman, Matthew // BMC Bioinformatics;2008 Supplement 10, Vol. 9, Special section p1 

    Background Trypanosoma brucei (T. brucei) is a single celled parasite, subspecies of which are causative agents of African sleeping sickness in humans and nagana in domestic animals. Sleeping sickness is endemic in about 36 countries in Sub- Saharan Africa and is threatening over 60 million...

  • Expression of Procyclin mRNAs during Cyclical Transmission of Trypanosoma brucei. Urwyler, Simon; Vassella, Erik; Van Den Abbeele, Jan; Renggli, Christina Kunz; Blundell, Pat; Barry, J. David; Roditi, Isabel // PLoS Pathogens;Nov2005, Vol. 1 Issue 3, p225 

    Trypanosoma brucei, the parasite causing human sleeping sickness, relies on the tsetse fly for its transmission. In the insect, EP and GPEET procyclins are the major surface glycoproteins of procyclic (midgut) forms of the parasite, with GPEET predominating in the early procyclic form and two...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics